期刊文献+

自体和异体输血对严重创伤患者凝血功能的影响分析 被引量:6

暂未订购
导出
摘要 目的探讨自体和异体输血对严重创伤患者凝血功能的影响。方法回顾性分析自体输血(治疗组)与异体输血(对照组)手术患者各30例的临床资料。结果回输前两组血红蛋白和血细胞比容均较手术前明显降低(P<0.05),回输后各项指标有明显回升(P<0.05),但仍低于手术前(P<0.05),两组患者组间比较差异则无统计学意义(P>0.05)。两组患者输血前较手术前存在明显的凝血功能障碍(P<0.05),回输后活化部分凝血活酶时间与凝血酶原时间都恢复正常(P>0.05),而对照组纤维蛋白原、血小板进一步下降(P<0.05)。结论自体输血可保证血流动力学的基本稳定,虽然凝血功能较手术前有一定减退,但回输后基本保持正常水平,值得推广应用。
出处 《国际检验医学杂志》 CAS 2012年第18期2287-2288,共2页 International Journal of Laboratory Medicine
  • 相关文献

参考文献12

二级参考文献56

  • 1匡培根,王国平,郎森阳,于生元,朱克.东菱精纯克栓酶治疗缺血性脑血管病[J].中国新药杂志,1994,3(6):36-39. 被引量:177
  • 2林建海,罗勇,鲁慧敏,刘宝裕.巴曲抗栓酶对肺原性心脏病病人血栓前状态的作用[J].新药与临床,1996,15(5):292-294. 被引量:6
  • 3许贻白,诸金水,王亚仙,何建方.急性缺血性中风患者血小板颗粒膜糖蛋白的动态变化及临床意义[J].中风与神经疾病杂志,1997,14(1):24-25. 被引量:21
  • 4Cosdgriff N, Moore EE, Sauaia A, et al. Predicting life-threatening coagulopathy in the massively transfused trauma patient: hypothennia and acidoses revisited[J]. J Trauma, 1997,42(5): 857-861.
  • 5Spahn DR, Rossaint R. Coagulopathy and blood component transfusion in trauma[J]. Br J Anaesth,2005,95(2):130-139.
  • 6Garrison JR, Richardson JD, Hilakos AS, et al. Predicting the need to pack early for severe intra-abdominal hemorrhage[ J]. J Trauma, 1996, 40(6) : 923-927.
  • 7Spivey M, Parr MJ. Therapeutic approaches in trauma-induced coagulapaday[ J ]. Minerva Anestesiol, 2005,71 ( 6 ) : 281-289.
  • 8Stainsby D, MacLennan S, Hamilton PJ. Management of massive blood loss: a template guideline[J]. Br J Anaesth,2000,85(3) :487-491.
  • 9Wada H, Minamidawa K, Wakita Y, et al. Hemostatic study before onset of disseminated intravaseular coagulation[ J]. Am J Hema-tol, 1993,43 (3) : 190-194.
  • 10Johi RR, Cross MH, Hansbro SD. Near-patient testing for coagulopathy after cardiac surgery[ J]. Br J Anaesth, 2003,90(4) : 499-501.

共引文献107

同被引文献40

  • 1刘建忠,何静,陈方祥,罗梅,郭庆山.术中自体血回输在脊柱手术中的应用[J].重庆医学,2007,36(21):2150-2151. 被引量:7
  • 2Liumbruno GM, Bennardello F, Lattanzio A, et al. Recom- mendations for the transfusion management of patients in the peri-operative period. I. The pre-operative period [J]. Blood Transfus, 2011, 9: 19-40.
  • 3Liumbruno GM, Bennardello F, Lattanzio A, et al. Recom- mendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period [J]. Blood Transfus, 2011, 9 : 189-217.
  • 4Shander A. Emerging risks and outcomes of blood transfusion in surgery [J]. Semin nematol, 2004, 41 (1 Suppl 1 ): 117-124.
  • 5Dasararaju R, Marques MB. Adverse effects of transfusion [J]. Cancer Control, 2015, 22: 16-25.
  • 6Santos AA, Silva JP, Silva LD, et al. Therapeutic options to minimize allogeneic blood transfusions and their adverse effects in cardiac surgery: A systematic review [ J]. Rev Bras Cir Cardiovasc, 2014, 29: 606-621.
  • 7Goodnough LT, Shander AS. Patient blood management [ J ]. Anesthesiology, 2012, 116 : 1367-1376.
  • 8Eliason JL, Clouse WD. Current management of infrarenal abdominal aortic aneurysms [ J ]. Surg Clin North Am, 2007, 87: 1017-1033.
  • 9Tadros RO, Faries PL, Ting W, et al. Update in the use of branched and fenestrated endografts to treat aortic aneurysms [ J]. Surg Techno Int, 2014, 24: 273-279.
  • 10Schwierz E, Kolvenbach RR, Yoshida R, et al. Experience with the sandwich technique in endovascular thoracoabdominal aortic aneurysm repair [J]. J Vas Surg, 2014, 59: 1562-1569.

引证文献6

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部